Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map.
Carolina RequeijoJavier BracchiglioneNicolás MezaRoberto Acosta-DigheroJosefina SalazarMarilina SanteroAdriana-Gabriela MeadeMaría Jesús QuintanaGerardo Rodríguez-GrijalvaSelva AnnaIvan SolaGerard UrrútiaXavier Bonfillnull nullPublished in: Clinical epidemiology (2023)
Patient-important outcomes beyond survival in advanced HBCs are insufficiently assessed by the available evidence. Future studies need to address these gaps to better inform decision-making processes.